Mizuho analyst Robert Mosca maintains DT Midstream (NYSE:DTM) with a Buy and raises the price target from $57 to $58.
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $54
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $50 to $54.